Galmed Pharmaceuticals Ltd. (EOCN): Net Income
$6.90M
Year ended 2025-12-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.90M | -8.0% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $7.50M | -27.2% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $10.30M | n/c | 2026-03-31, From 2023-01-01 |
| 2022-12-31 | $17.90M | -44.8% | 2025-04-02, From 2022-01-01 |
| 2021-12-31 | $32.40M | n/c | 2024-04-04, From 2021-01-01 |
| 2020-12-31 | -$28.80M | n/c | 2023-03-29, From 2020-01-01 |
| 2019-12-31 | $20.50M | n/c | 2022-05-02, From 2019-01-01 |
| 2018-12-31 | -$9.86M | n/m | 2021-03-18, From 2018-01-01 |
| 2017-12-31 | -$12.30M | n/m | 2020-03-12, From 2017-01-01 |
| 2016-12-31 | -$16.95M | n/m | 2019-03-13, From 2016-01-01 |
| 2015-12-31 | -$10.62M | n/m | 2018-03-13, From 2015-01-01 |
| 2014-12-31 | -$9.10M | n/m | 2017-03-23, From 2014-01-01 |
| 2013-12-31 | -$17.48M | n/m | 2016-03-22, From 2013-01-01 |
| 2012-12-31 | -$3.15M | n/a | 2015-03-31, From 2012-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $6.90M | -8.0% |
| Lite Strategy, Inc. (LITS) | 2025-06-30 | -$15.95M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$11.23M | n/m |
| Genelux Corp (GNLX) | 2025-12-31 | -$32.15M | n/m |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | -$12.16M | n/m |
| Clene Inc. (CLNN) | 2025-12-31 | -$26.17M | n/m |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | -$24.86M | n/m |
| Galectin Therapeutics Inc (GALT) | 2025-12-31 | -$30.84M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$16.59M | n/m |
Compare EOCN, LITS, ALLR, GNLX side by side · Screen every company in Pharmaceutical Preparations ↗